These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29203418)

  • 1. Electronic medical records can be used to emulate target trials of sustained treatment strategies.
    Danaei G; García Rodríguez LA; Cantero OF; Logan RW; Hernán MA
    J Clin Epidemiol; 2018 Apr; 96():12-22. PubMed ID: 29203418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival.
    Danaei G; García Rodríguez LA; Fernandez Cantero O; Hernán MA
    Diabetes Care; 2013 May; 36(5):1236-40. PubMed ID: 23248196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emulating a target trial in case-control designs: an application to statins and colorectal cancer.
    Dickerman BA; García-Albéniz X; Logan RW; Denaxas S; Hernán MA
    Int J Epidemiol; 2020 Oct; 49(5):1637-1646. PubMed ID: 32989456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.
    Danaei G; Rodríguez LA; Cantero OF; Logan R; Hernán MA
    Stat Methods Med Res; 2013 Feb; 22(1):70-96. PubMed ID: 22016461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of secondary prevention practice in poststroke and coronary heart disease patients.
    Vaněk J; Mayer O; Seidlerová J; Bruthans J; Kielbergerová L; Wohlfahrt P; Krajčoviechová A; Filipovský J; Cífková R
    Public Health; 2016 Aug; 137():64-72. PubMed ID: 26996311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
    J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalizing the per-protocol treatment effect: The case of ACTG A5095.
    Lu H; Cole SR; Hall HI; Schisterman EF; Breger TL; K Edwards J; Westreich D
    Clin Trials; 2019 Feb; 16(1):52-62. PubMed ID: 30326736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.
    Wood DA; Kotseva K; Connolly S; Jennings C; Mead A; Jones J; Holden A; De Bacquer D; Collier T; De Backer G; Faergeman O;
    Lancet; 2008 Jun; 371(9629):1999-2012. PubMed ID: 18555911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intensive treatment with atorvastatin versus standard doses of statins on the risk of stroke. A meta-analysis from five randomized trials including 25,709 patients].
    Fernándezde Bobadilla J; Moreno R; Fernández C; Martínez A; Sánchez-Maestre C; Ezpeleta-Echevarri D
    Rev Neurol; 2009 Jun 1-15; 48(11):561-5. PubMed ID: 19472152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis at 6 months for coronary and cerebrovascular patients: impact of antiplatelet agents and statins: results from the Prevenir III study.
    Ferrières J; Cambou JP; Cantet C; Guize L
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):55-61. PubMed ID: 16552472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
    Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
    JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emulating a target trial of statin use and risk of dementia using cohort data.
    Caniglia EC; Rojas-Saunero LP; Hilal S; Licher S; Logan R; Stricker B; Ikram MA; Swanson SA
    Neurology; 2020 Sep; 95(10):e1322-e1332. PubMed ID: 32753444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
    Lachaine J; Rinfret S; Merikle EP; Tarride JE
    Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
    Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Drugs; 2004; 64 Suppl 2():43-60. PubMed ID: 15765890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.
    Murray EJ; Hernán MA
    Clin Trials; 2016 Aug; 13(4):372-8. PubMed ID: 26951361
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.